Study S000726

An Open-label, One-sequence Cross Over, Single Centre Trial, Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02243098
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 31
Start: 2014-09-16
Primary completion: 2015-04-07
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes; Healthy
Interventions: DRUG:semaglutide; DRUG:digoxin; DRUG:atorvastatin
Results posted: FALSE
Secondary identifiers: EUDRACT_NUMBER:2013-001288-22; OTHER:U1111-1140-8551

Registered primary outcomes

Area under the atorvastatin plasma concentration-time curve [From time 0 to 72 hours after a single dose]
Area under the digoxin plasma concentration-time curve [From time 0 to 120 hours after a single dose]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0020536	Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects. Hausner H, Clinical pharmacokinetics	2017	Other trial	PMID 28349387 DOI	registry reference RESULT:28349387